Credit Suisse: Regeneron Now Worth $550/Share

By: via Benzinga
In a report published Friday, Credit Suisse analysts maintained an Outperform rating on Regeneron Pharmaceuticals Inc (NASDAQ: REGN), ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.